Drug development in the connected world: a new paradigm for drug discovery

Drug Development in the Connected World
MIT Media Lab, Massachusetts Institute of Technology

As big pharma companies have eperienced an industry-wide decline in R&D productivity over the last decade, partnering has become an increasingly necessary capability and a plethora of collaborations that support projects at every stage of drug discovery and development has emerged. Big pharmas, research-stage biotechs, smaller pharmas, CROs, non-profit organizations and patient advocacy groups have become essential collaborators, becoming networked R&D organizations. This talk, delivered as part of an MIT workshop on Designing the Future of Drug Development, focused on the implication of these collaborative structures in clinical development.